Early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies: A retrospective single-center studyCentral MessagePerspective

Background: Zone 0 landing hybrid thoracic endovascular aortic repair (TEVAR) includes a few moderately invasive surgical procedures. To reduce invasiveness, TEVAR with a branched aortic arch stent-graft can be considered. This study aimed to elucidate the effectiveness of performing TEVAR using a B...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomoaki Kudo, MD, PhD, Toru Kuratani, MD, PhD, Kazuo Shimamura, MD, PhD, Yoshiki Sawa, MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:JTCVS Techniques
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666250720305423
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849765692164800512
author Tomoaki Kudo, MD, PhD
Toru Kuratani, MD, PhD
Kazuo Shimamura, MD, PhD
Yoshiki Sawa, MD, PhD
author_facet Tomoaki Kudo, MD, PhD
Toru Kuratani, MD, PhD
Kazuo Shimamura, MD, PhD
Yoshiki Sawa, MD, PhD
author_sort Tomoaki Kudo, MD, PhD
collection DOAJ
description Background: Zone 0 landing hybrid thoracic endovascular aortic repair (TEVAR) includes a few moderately invasive surgical procedures. To reduce invasiveness, TEVAR with a branched aortic arch stent-graft can be considered. This study aimed to elucidate the effectiveness of performing TEVAR using a Bolton (Bolton Medical, Inc, Sunrise, Fla) branched endograft by analyzing early and midterm results. Methods: We enrolled 28 patients (mean age, 78.4 years) who underwent TEVAR with the Bolton branched endograft in Osaka University Hospital between October 2012 and June 2018 with a mean follow-up period of 4.0 years. Double-side and single-side branched devices were used in 24 (85.7%) and 4 (14.3%) patients, respectively. Results: All procedures were successful; no cases of endoleak or conversion to open repair were noted during the 30-day postoperative period. The perioperative stroke rate was 14.3% (4 out of 28); midterm stroke was not detected. All patients with perioperative stroke had atheroma grade ≥2 in the brachiocephalic artery. No type 1a endoleak was reported during the early or midterm results. The cumulative survival rate, aorta-related death-free rate, and aortic event-free survival rate at 5 years were 80.8%, 95.8%, and 81.6%, respectively. Conclusions: We achieved satisfactory early and midterm results by using a Bolton branched endograft for high-risk patients with arch pathologies except for high postoperative stroke. Although this treatment method is associated with postoperative stroke, performing strict evaluation of atheroma may prevent such complication. By preventing intraoperative stroke, TEVAR with this custom-made Bolton branched endograft may be considered a less-invasive treatment.
format Article
id doaj-art-4214d71cd7094ce6bf7c4ee406f65c74
institution DOAJ
issn 2666-2507
language English
publishDate 2020-12-01
publisher Elsevier
record_format Article
series JTCVS Techniques
spelling doaj-art-4214d71cd7094ce6bf7c4ee406f65c742025-08-20T03:04:46ZengElsevierJTCVS Techniques2666-25072020-12-014172510.1016/j.xjtc.2020.09.023Early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies: A retrospective single-center studyCentral MessagePerspectiveTomoaki Kudo, MD, PhD0Toru Kuratani, MD, PhD1Kazuo Shimamura, MD, PhD2Yoshiki Sawa, MD, PhD3Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan; Address for reprints: Tomoaki Kudo, MD, PhD, and Yoshiki Sawa, MD, PhD, Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871 Japan.Department of Minimally Invasive Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, JapanDepartment of Minimally Invasive Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, JapanDepartment of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan; Address for reprints: Tomoaki Kudo, MD, PhD, and Yoshiki Sawa, MD, PhD, Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871 Japan.Background: Zone 0 landing hybrid thoracic endovascular aortic repair (TEVAR) includes a few moderately invasive surgical procedures. To reduce invasiveness, TEVAR with a branched aortic arch stent-graft can be considered. This study aimed to elucidate the effectiveness of performing TEVAR using a Bolton (Bolton Medical, Inc, Sunrise, Fla) branched endograft by analyzing early and midterm results. Methods: We enrolled 28 patients (mean age, 78.4 years) who underwent TEVAR with the Bolton branched endograft in Osaka University Hospital between October 2012 and June 2018 with a mean follow-up period of 4.0 years. Double-side and single-side branched devices were used in 24 (85.7%) and 4 (14.3%) patients, respectively. Results: All procedures were successful; no cases of endoleak or conversion to open repair were noted during the 30-day postoperative period. The perioperative stroke rate was 14.3% (4 out of 28); midterm stroke was not detected. All patients with perioperative stroke had atheroma grade ≥2 in the brachiocephalic artery. No type 1a endoleak was reported during the early or midterm results. The cumulative survival rate, aorta-related death-free rate, and aortic event-free survival rate at 5 years were 80.8%, 95.8%, and 81.6%, respectively. Conclusions: We achieved satisfactory early and midterm results by using a Bolton branched endograft for high-risk patients with arch pathologies except for high postoperative stroke. Although this treatment method is associated with postoperative stroke, performing strict evaluation of atheroma may prevent such complication. By preventing intraoperative stroke, TEVAR with this custom-made Bolton branched endograft may be considered a less-invasive treatment.http://www.sciencedirect.com/science/article/pii/S2666250720305423endovascular graftendovascular procedureaortic arch aneurysmstroke
spellingShingle Tomoaki Kudo, MD, PhD
Toru Kuratani, MD, PhD
Kazuo Shimamura, MD, PhD
Yoshiki Sawa, MD, PhD
Early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies: A retrospective single-center studyCentral MessagePerspective
JTCVS Techniques
endovascular graft
endovascular procedure
aortic arch aneurysm
stroke
title Early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies: A retrospective single-center studyCentral MessagePerspective
title_full Early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies: A retrospective single-center studyCentral MessagePerspective
title_fullStr Early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies: A retrospective single-center studyCentral MessagePerspective
title_full_unstemmed Early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies: A retrospective single-center studyCentral MessagePerspective
title_short Early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies: A retrospective single-center studyCentral MessagePerspective
title_sort early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies a retrospective single center studycentral messageperspective
topic endovascular graft
endovascular procedure
aortic arch aneurysm
stroke
url http://www.sciencedirect.com/science/article/pii/S2666250720305423
work_keys_str_mv AT tomoakikudomdphd earlyandmidtermresultsofthoracicendovascularaorticrepairusingabranchedendograftforaorticarchpathologiesaretrospectivesinglecenterstudycentralmessageperspective
AT torukuratanimdphd earlyandmidtermresultsofthoracicendovascularaorticrepairusingabranchedendograftforaorticarchpathologiesaretrospectivesinglecenterstudycentralmessageperspective
AT kazuoshimamuramdphd earlyandmidtermresultsofthoracicendovascularaorticrepairusingabranchedendograftforaorticarchpathologiesaretrospectivesinglecenterstudycentralmessageperspective
AT yoshikisawamdphd earlyandmidtermresultsofthoracicendovascularaorticrepairusingabranchedendograftforaorticarchpathologiesaretrospectivesinglecenterstudycentralmessageperspective